Happy Head Prescription TopicalvsKeeps

Happy Head's topical targets hair loss two ways at once. Minoxidil widens scalp blood vessels and is converted by an enzyme in the follicle (sulfotransferase) into its active form, which prolongs the hair's growth (anagen) phase and can thicken strands. Finasteride blocks 5-alpha-reductase, the enzyme that turns testosterone into DHT, the hormone that shrinks genetically susceptible follicles. Applied to the scalp, finasteride lowers scalp DHT while keeping blood levels much lower than the oral pill. Add-ons such as retinoic acid (tretinoin) are intended to aid minoxidil penetration, while hydrocortisone or ketoconazole may help calm scalp irritation and inflammation.

Keeps itself is a telehealth service, not a drug; an online clinician reviews your intake and prescribes generic medications shipped to your door. The actual hair regrowth comes from two well-studied ingredients. Finasteride is an oral Type II 5-alpha-reductase inhibitor that lowers scalp DHT, the hormone that miniaturizes genetically susceptible follicles, thereby slowing loss and allowing some regrowth. Minoxidil is a topical vasodilator thought to prolong the follicle's growth (anagen) phase and increase blood flow to follicles, helping produce thicker hair; its exact mechanism in hair growth is still not fully understood. Keeps also offers a compounded once-daily topical finasteride/minoxidil gel and foam (0.25% finasteride, 5% minoxidil), ketoconazole 2% shampoo, and may offer dutasteride for some patients.

The individual ingredients are well-studied, though Happy Head has not published a peer-reviewed trial of its specific product. Topical minoxidil (2% and 5%) is the only FDA-approved topical for androgenetic alopecia, with randomized trials consistently showing increased hair counts. A phase III randomized, placebo-controlled trial of a topical finasteride spray (Piraccini et al., published 2022) found a +20.2 vs +6.7 adjusted mean hair-count change versus placebo at 24 weeks (P<0.001), an effect similar to oral finasteride but with maximum plasma drug levels more than 100 times lower; serum DHT fell about 34.6% with the topical versus 55.6% with oral finasteride. A 2025 systematic review and meta-analysis of randomized controlled trials found topical minoxidil-finasteride combinations outperformed minoxidil alone on hair density and diameter. Note that this evidence is for similar compounded or spray formulations, not Happy Head's exact product, and the company's before/after photos are marketing testimonials, not controlled data. Most users who respond see results in roughly 3 to 6 months.

The medications Keeps prescribes have strong evidence; Keeps has not published its own large clinical trials. In a multinational study of men with male pattern hair loss, oral finasteride 1 mg daily produced durable hair-count improvement over five years while placebo users progressively lost hair (p<0.001 for all endpoints; PubMed 11809594). Earlier pivotal trials showed roughly two-thirds of finasteride users had visible improvement versus continued loss on placebo. For minoxidil, a 48-week randomized trial in 393 men found 5% topical minoxidil significantly superior to 2% and placebo in non-vellus hair count, and a separate 16-week foam trial in 352 men showed significant hair-count gains versus placebo (P<.0001). Smaller studies suggest combining finasteride and minoxidil may outperform either alone. Benefits require continuous use; stopping reverses gains within months.

Common local effects include scalp redness, itching, burning, dryness, and flaking, plus a temporary increase in shedding in the first 6 to 8 weeks of minoxidil use (often a transient phase as follicles cycle, though persistent or heavy shedding warrants checking with your prescriber). Propylene-glycol-containing bases can trigger contact dermatitis, and higher 8% minoxidil may irritate more than standard 5%. The finasteride component, though absorbed far less than the pill, can still cause systemic effects: in April 2025 the FDA issued a safety alert about compounded topical finasteride, citing 32 adverse-event reports (2019-2024) including erectile dysfunction, decreased libido, depression, anxiety, suicidal ideation, brain fog, fatigue, insomnia, and testicular pain, and noting that most reports described effects that persisted after stopping. Report any mood changes, sexual dysfunction, chest symptoms, or unwanted facial or body hair growth to your prescriber promptly.

Minoxidil's common side effects are local: scalp itching, dryness, flaking, or irritation, plus possible temporary "shedding" in the first weeks. Unwanted facial or body hair can occur if it spreads beyond the scalp. Finasteride's notable risks are sexual: in Merck's Phase III trials about 1.3-1.8% of men reported decreased libido, erectile dysfunction, or ejaculation problems (versus roughly 0.7-1.3% on placebo), usually reversible after stopping. A debated but reported condition, "post-finasteride syndrome," describes sexual or mood symptoms persisting after discontinuation. The FDA-approved finasteride 1 mg (Propecia) label lists depression and, since an August 2022 update, suicidal ideation and behavior among postmarketing adverse reactions. Finasteride also lowers PSA, and the label notes a possible increased risk of high-grade prostate cancer. Seek medical care for mood changes, persistent sexual dysfunction, breast lumps or tenderness, or signs of an allergic reaction.

As of 2026, Happy Head's topical finasteride-and-minoxidil solution is priced at about $49 for a promotional first order, then roughly $63 per month on a subscription (about $79 as a one-time purchase). More complex multi-ingredient formulas and bundles (for example with dutasteride, liposomal delivery, or an added oral SuperCapsule) cost more, commonly ranging from about $79 up to roughly $178 per month depending on the combination. A 6-month satisfaction guarantee refunds your most recent month's supply if you are unhappy, and you can pause, skip, or cancel anytime. Because these are compounded prescriptions, insurance reimbursement is unlikely, though FSA/HSA cards may be accepted; expect to pay out of pocket. For comparison, generic 5% minoxidil alone runs roughly $10 to $15 per month, so you are paying a premium for the added finasteride, customization, and telehealth service.

As of 2026, Keeps positions itself as budget-friendly: individual plans often start around $10-25 per month (minoxidil at the low end, generic finasteride roughly $17-25), with combination and compounded multi-ingredient formulas costing more, plus a roughly $5 shipping fee per order. Longer 6- or 12-month commitments usually lower the per-month price, and the online consultation is typically free or low-cost. Insurance generally does not cover cosmetic hair-loss treatment. Because these are generics, it's worth comparing: a GoodRx coupon for generic finasteride or minoxidil at a local pharmacy can sometimes match or beat subscription pricing, though you'd manage the prescription and refills yourself. Keeps' parent company agreed to be acquired in late 2025, so verify current prices on the Keeps website before subscribing.

Best for adults with early-to-moderate androgenetic alopecia (male- or female-pattern thinning) who want combination minoxidil-plus-finasteride therapy but prefer a topical over an oral pill, or who did not tolerate oral finasteride's systemic side effects. A telehealth dermatologist reviews each case and customizes the formula. Who should avoid it: anyone who is pregnant, breastfeeding, or may become pregnant must not handle finasteride or dutasteride (risk of birth defects in a male fetus). People with cardiovascular disease or low blood pressure should be cautious with high-dose minoxidil and talk to a doctor first, and those with a history of depression or sexual dysfunction should weigh finasteride's potential mood and sexual side effects with their prescriber. It is not appropriate for scarring alopecia, sudden or patchy total hair loss, or undiagnosed shedding; see a doctor for an evaluation first.

Keeps is designed for adult men (18+) with hereditary male pattern hair loss (androgenetic alopecia), and works best on early-to-moderate thinning at the crown and hairline rather than long-established bald areas. Finasteride is FDA-indicated for men only and is contraindicated in women who are or may become pregnant, who should not handle crushed or broken tablets, because it can cause genital abnormalities in a male fetus. Men with a history of depression or mood disorders, men planning to father children, or those with prostate-cancer concerns should discuss finasteride carefully with a clinician, since it lowers PSA levels (affecting prostate-cancer screening) and its label notes that 5-alpha-reductase inhibitors may increase the risk of high-grade prostate cancer. Men who want to avoid hormonal side effects entirely can use minoxidil alone.